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Zillikens, 2013), no associated malig-
nancy was observed. In contrast, in
lichen sclerosus, carcinomas of the
genitalia and the skin were revealed
(Powell and Wojnarowska, 1999). A
possible drawback of this study is its
reliance on the ICD-10 coding of
doctors from different specialities.
Although the large majority of auto-
immune bullous diseases are diagnosed
by dermatologists, coding of these
disorders by non-dermatologists might
have led to mistakes. On the basis of the
coding of pemphigoid gestationis in one
man and four female patients older than
50 years, the false-coding rate was
estimated to be 4%.
The present findings will be relevant
for the future care of patients with
autoimmune bullous disorders. Regard-
less of the reason for the higher inci-
dence of cancer in some of these
diseases, an increased awareness in com-
bination with regular differential blood
counts and inspection of the entire skin,
as well as routinely performed gastro-
and coloscopy in patients with pemphi-
gus vulgaris might be helpful to detect
the associated malignancies as early as
possible in the majority of patients.
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TO THE EDITOR
The Kindler syndrome (KS; OMIM173650)
is a rare autosomal recessive disorder
characterized by trauma-induced blis-
tering, cutaneous atrophy, and progres-
sive poikiloderma, in association with
mucosal inflammation (Kindler, 1954;
Lai-Cheong and McGrath, 2010; Has
et al., 2011). Some individuals also
suffer from photosensitivity, which tends
to lessen with advancing age. Marked
skin atrophy, the hallmark of the disease,
develops early in life particularly on the
dorsal aspects of the hands and feet and
becomes generalized in most cases
by adolescence. Other clinical features
include mucosal stenosis, gastrointe-
stinal symptoms, and increased risk for
non-melanoma skin cancer, with deve-
lopment of squamous cell carcinomas
in acral skin and the mouth with
considerable phenotypic variability
(Cardin-Langlois et al., 2010; Has
et al., 2010; Lai-Cheong and McGrath,
2010; Has et al., 2011). Histopathology
of the skin shows hyperkeratosis, epi-
dermal atrophy, loss of rete ridges, and
focal vacuolization of the basal layer
of the epidermis, consistent with poiki-
loderma. Transmission electron micro-
scopy of the non-blistered skin demon-
strates reduplication of the basal lamina
with focal interruptions of the lamina
densa, a diagnostic feature that can be
demonstrated by immunofluorescence
staining of the skin with an anti-type IV
or type VII collagen antibody or by
transmission electron microscopy.Accepted article preview online 19 January 2015; published online 5 March 2015
Abbreviations: EB, epidermolysis bullosa; KS, the Kindler syndrome
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KS has recently been included in the
group of cutaneous fragility syndromes
as a subtype of epidermolysis bullosa
(EB; Fine et al., 2014). KS is often
diagnosed at birth as EB because of
considerable overlap with dystrophic
EB and EB simplex with mottled pig-
mentation. However, later on, develop-
ment of progressive skin atrophy and
poikiloderma, acral blistering, mucosal
inflammation, and photosensitivity are
diagnostic, and the diagnosis can be
confirmed by demonstration of loss-of-
function mutations in the FERMT1 gene
(also known as KIND1). Since the first
demonstration of mutations in the
FERMT1 gene (Jobard et al., 2003;
Siegel et al., 2003), a total of 59
distinct mutations have been reported
(www.hgmd.org). The FERMT1 gene
encodes kindlin-1, the fermitin family
homolog 1 and a component of kerati-
nocyte focal adhesions, which has a
critical role in keratinocyte migration,
proliferation, and adhesion (Lai-Cheong
et al., 2009). In this study, we report the
evaluation of 13 Iranian families with
440 affected individuals with KS identi-
fied through contacts with dermatology
departments and pediatric centers
in Iran (for pedigrees, see Figure 1).
Clinical features of three of these
families have previously been reported
(Ghaninejad et al., 2004; Yazdanfar and
Hashemi, 2009; Ebrahimi Daryani and
Abbaszadeh, 2013).
Pedigree analysis of these families
suggested a high degree of consangui-
nity, a tradition in Iranian society
(between 30 and 50% of all marriages).
The families were personally examined
by dermatologists who are authors (MB,
SS, AY, and AHE) and by experts in
medical genetics (LY and HV), and the
diagnostic clinical features were care-
fully recorded (Supplementary Figure 1S
and Supplementary Table 1S online).
The diagnosis was confirmed in one
family with immunofluorescence, which
demonstrated broadened distribution of
type IV and type VII collagen at the
dermal-epidermal basement memb-
rane zone (Supplementary Figure 1Si,
j online). DNA was isolated from per-
ipheral blood leukocytes after a written,
informed consent approved by the Insti-
tutional Review Board of Pasteur Insti-
tute of Iran, and mutation analysis was
performed by PCR amplification of pro-
moter region and all 15 exons and
flanking intronic sequences of FERMT1,
followed by bidirectional Sanger
sequencing. The primer pairs were
designed to include at least 70 bp flank-
ing intronic sequences to allow evalua-
tion of the splice junctions. Initial
a Family1
c.550_551insA
b Family2
c.1139+2 T>C
Family3c
c.957+1G>A
d Family4 e Family5
c.614G>A c.1176T>G
f Family6 g Family7
c.910G>T c.328C>T
h Family8 i Family9
CA c.1383C>A
j Family10 k Family11
2.6 kb del
g. 6109607—6112272 delc.1718+2T>C
c.994_995delCA
Figure 1. Pedigrees of 11 families affected by the Kindler syndrome with homozygous mutations identified in the FERMT1 gene. (a) Insertion of an A-nucleotide
(c.550_551insA) in exon 5; (b) substitution c.1139þ2T4C in intron 9 at donor splice site; (c) substitution c.957þ 1G4A in intron 7 at donor splice site; (d)
nonsense mutation p.Trp205X in exon 5 (c.614G4A); (e) nonsense mutation p.Tyr392X in exon 10 (c.1176T4G); (f) nonsense mutation p.Glu304X in exon 7
(c.910G4T); (g) nonsense mutation p.Arg110X in exon 3 (c.328C4T); (h) dinucleotide deletion mutation c.994_995delCA in exon 8, which causes premature
stop codon (p.Gln332GlyfsTer9); (i) nonsense mutation p.Tyr461X in exon 12 (c.1383C4A); (j) c.1718þ 2T4C donor splice site mutation; (k) Alu-mediated
2,665 bp deletion g.6109607-6112272del.
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sequencing identified homozygous
pathogenic mutations in FERMT1 in nine
families (nos. 1–9; Table 1). It should be
noted that in one family (no. 2 in
Table 1), there were two homozygous
mutations, an obligatory pathogenic
splice site mutation c.1139þ 2T4C
and a missense mutation p.Arg297Gly,
in all affected family members, whereas
the unaffected individuals, including the
proband’s parents, were heterozygous
for both mutations. The latter amino acid
substitution is potentially pathogenic
because it is not present in the single-
nucleotide polymorphism database
(Exome Variant Server) and bioinfor-
matics prediction by PolyPhen-2 (genet-
ics.bwh.harvard.edu/pph2, Boston, MA)
and SIFT (Sift.jcvi.org, Rockville, MD)
programs indicated that the change is
‘‘Possibly Damaging’’ (score 0.92) and
‘‘Damaging’’ (score 0), respectively. No
mutation in FERMT1 gene was initially
found in the remaining four families
(nos. 10–13), and no sequence variants
were present in the promoter region,
5 kb upstream of the coding region in
exon 2. Consequently, taking advantage
of the fact that all families are consan-
guineous, homozygosity mapping was
performed with informative single-
nucleotide polymorphisms (SNPs) in
the FERMT1 locus (Supplementary
Table S2 online). Two of the families
(nos. 10 and 11) were homozygous for
all markers, and subsequent further ana-
lysis identified mutations in FERMT1.
Specifically, affected individuals in
family no. 10 had a homo-
zygous splice site mutation,
c.1718þ 2T4C, whereas patients in
family no. 11 had a homozygous
2,665 bp deletion mutation spanning
from intron 4 to intron 5 and deleting
exon 5 of FERMT1. Thus, FERMT1
mutations were identified in 11 families,
9 of them being previously unpublished.
Of the newly described mutations, four
were nonsense, one missense, three
splice site mutations, and one large
deletion. All mutations, except the mis-
sense mutations, are predicted to lead to
loss of functional kindlin-1 as a result of
nonsense mutations or aberrant splicing
leading to frame shift and premature
termination of translation. The remain-
ing two families (nos. 12 and 13), in
spite of consanguinity, were heterozy-
gous for all SNPs, apparently excluding
FERMT1 locus for mutations
(Supplementary Table S2 online). The
two families, with some atypical
features, may represent new clinical
entities with overlapping features with
KS and are currently being examined
further. It should be noted that the
mutation detection strategy initially
utilized in this study does not detect
large deletions, which have been
reported in FERMT1 in some cases of
KS (Has et al., 2008; Zhou et al., 2009;
Fuchs-Telem et al., 2014; Has et al.,
2015), or the mutations may reside in
untranslated regions in the introns or in
30-untranslated region. In this context, it
has been recently emphasized that there
is no evidence of locus heterogeneity in
KS (Fuchs-Telem et al., 2014).
In summary, we have ascertained 13
Iranian families with the diagnosis of KS,
and, in 11 families, homozygous muta-
tions in the FERMT1 gene could be
identified, nine of them being previously
unpublished. These mutations add to the
existing KS mutations database, with
implications for prenatal testing and
preimplantation genetic diagnosis in
families at risk for recurrence. The pre-
cise knowledge of the mutations will
also help in identification of heterozy-
gous carriers in extended families with a
history of KS.
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Table 1. Mutation analysis of the FERMT1 gene in Iranian families affected by the Kindler syndrome
Number
of Family Exon/intron Mutation at DNA level Mutation at protein level Predicted consequence*
Mutation first reported
in reference
1 Exon 5 c.550_551insA p.Ser184LeufsTer1 Frame shift This study
2 Exon 7
Intron 9
c. 889A4G
c.1139þ2T4C
p.Arg297Gly Missense
Donor splice site
This study
This study
3 Intron 7 c.957þ 1G4A Donor splice site This study
4 Exon 5 c.614G4A p.Trp205X PTC Siegel et al., 2003
5 Exon 10 c. 1176T4G p.Tyr392X PTC This study
6 Exon 7 c.910G4T p.Glu304X PTC This study
7 Exon 3 c.328C4T p.Arg110X PTC Has et al., 2009
8 Exon 8 c.994_995delCA p.Gln332GlyfsTer9 PTC This study
9 Exon 12 c.1383C4A p.Tyr461X PTC This study
10 Intron 13 c.1718þ2T4C Donor splice site Fassihi et al., 2005
11 Exon 5 g.6109607_6112272del 2,664 bp Alu-mediated deletion This study
Abbreviation: PTC, premature termination codon.
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TO THE EDITOR
Segmental overgrowth syndromes, con-
sisting of a spectrum of disorders with
vascular, cutaneous, and skeletal abnor-
malities, are sporadic, nonhereditary
disorders (Lindhurst et al., 2011;
Biesecker and Spinner, 2013). It was
originally postulated by Happle (1987)
that such disorders arise as a result of
mosaic somatic mutations and that
complete heterozygosity for the causal
mutation could be either lethal to the
affected individual or the affected
person would be incapable of germline
transmission. The prototype of the
mosaic postnatal overgrowth syndromes
is the Proteus syndrome commonly mani-
festing with connective tissue nevi and
bone overgrowth, but the central nervous
system and the eyes can also be affected.
The tissue overgrowth in Proteus syn-
drome is noncongenital and progressive,
the diagnosis is often delayed, and the
cases can be difficult to manage. The
Proteus syndrome is caused by hetero-
zygous activating mutations in the AKT1
gene (Biesecker, 2006).
A condition in differential diagnosis
with the Proteus syndrome is the
recently described disorder, CLOVES
syndrome (congenital lipomatous asym-
metric overgrowth of the trunk with
lymphatic, capillary, venous, andAccepted article preview online 23 January 2015; published online 19 February 2015
Abbreviations: CLOVES, congenital lipomatous overgrowth with vascular malformations, epidermal nevi
and skeletal abnormalities; MCAP, megalencephaly/hemimegalencephaly-capillary malformation
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